{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:53:08Z","timestamp":1772895188363,"version":"3.50.1"},"reference-count":97,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"publisher","award":["(QUCP-CHS-2022-483) and (QUPD-CHS-23\/24-563)."],"award-info":[{"award-number":["(QUCP-CHS-2022-483) and (QUPD-CHS-23\/24-563)."]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Breast cancer is a widespread and aggressive disease, with 2.3 million new cases globally in 2022. Metastasis, the spread of cancer cells to distant organs, remains a leading cause of breast cancer-related mortality. Current treatment options, particularly traditional chemotherapeutic drugs, are often associated with severe side effects, emphasizing the urgent need for safer and more effective therapeutic alternatives. Triple-negative breast cancer (TNBC) represents one of the most aggressive breast cancer subtypes, characterized by the absence of estrogen receptors (ER), receptors (PR), and HER2 expression. The human TNBC cell line MDA-MB-231, was selected in this study due to its aggressive, metastatic phenotype and its well-established use in zebrafish xenograft models. This makes it a highly relevant platform for preliminary\n                    <jats:italic>in vivo<\/jats:italic>\n                    evaluation of novel plant-derived compounds, particularly those targeting hard-to-treat breast cancer subtypes such as TNBC.\n                    <jats:italic>Elaeagnus angustifolia<\/jats:italic>\n                    (EA), commonly known as Russian olive, has attracted interest for its antimicrobial, anti-inflammatory, and antioxidant properties. However, its potential anticancer activity, especially against TNBC, remains relatively unexplored. This research investigated the efficacy of EA extract against MDA-MB-231 TNBC cells using a wild-type AB zebrafish model. A key objective was to evaluate the toxicological profile of EA across multiple physiological parameters in zebrafish, including developmental, cardiovascular, neuromuscular, and hepatic functions. The study identified safe, non-toxic concentrations of EA extract (0.5 mg\/mL and 0.75 mg\/mL). Moreover, treatment with EA in zebrafish xenografts led to a dose-dependent reduction in fluorescence intensity of injected TNBC cells, suggesting suppression of tumor cell proliferation and survival.. These findings suggest that EA warrant further investigation as a potential anticancer agent for TNBC. The observed safety profile and preliminary anti-tumor effects in zebrafish provide a foundation for future mechanistic and mammalian studies.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0344247","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:40:47Z","timestamp":1772822447000},"page":"e0344247","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unraveling the therapeutic potential of Elaeagnus angustifolia extract on triple-negative breast cancer (TNBC): An investigation using zebrafish model"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6643-3655","authenticated-orcid":true,"given":"Haya","family":"Abuhijleh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9656-8367","authenticated-orcid":true,"given":"Zain","family":"Zakria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiba","family":"Bawadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayat","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ala-Eddin","family":"Al Moustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3524-7962","authenticated-orcid":true,"given":"Abdullah","family":"Shaito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7855-4001","authenticated-orcid":true,"given":"Maha","family":"Al-Asmakh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"pone.0344247.ref001"},{"key":"pone.0344247.ref002","doi-asserted-by":"crossref","first-page":"632079","DOI":"10.3389\/fphar.2020.632079","article-title":"Advanced approaches to breast cancer classification and diagnosis","volume":"11","author":"M Zubair","year":"2021","journal-title":"Front Pharmacol"},{"key":"pone.0344247.ref003","first-page":"61","article-title":"Molecular profiling for breast cancer: A comprehensive review","volume":"5","author":"M Kittaneh","year":"2013","journal-title":"Biomark Cancer"},{"issue":"2","key":"pone.0344247.ref004","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/JOC.JOC_117_18","article-title":"Hormone Receptors and Human Epidermal Growth Factor (HER2) expression in fine-needle aspirates from metastatic breast carcinoma - Role in Patient Management","volume":"36","author":"IM Francis","year":"2019","journal-title":"J Cytol"},{"key":"pone.0344247.ref005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3121\/cmr.2008.825","article-title":"Breast cancer subtypes based on ER\/PR and Her2 expression: comparison of clinicopathologic features and survival","volume":"7","author":"AA Onitilo","year":"2009","journal-title":"Clin Med Res"},{"key":"pone.0344247.ref006","article-title":"Subtypes of breast cancer","author":"E Orrantia-Borunda","year":"2022","journal-title":"Breast Cancer"},{"issue":"6797","key":"pone.0344247.ref007","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"CM Perou","year":"2000","journal-title":"Nature"},{"key":"pone.0344247.ref008","year":"2025"},{"issue":"11","key":"pone.0344247.ref009","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease","volume":"13","author":"G Bianchini","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"pone.0344247.ref010","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: Clinical features and patterns of recurrence","volume":"13","author":"R Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"pone.0344247.ref011","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amsu.2019.11.021","article-title":"Molecular classification of breast cancer: A retrospective cohort study","volume":"49","author":"FK Al-Thoubaity","year":"2019","journal-title":"Ann Med Surg (Lond)"},{"key":"pone.0344247.ref012","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12672-020-00387-1","article-title":"Estrogen receptor positive and progesterone receptor negative breast cancer: The role of hormone therapy","volume":"11","author":"R Dembinski","year":"2020","journal-title":"Horm Cancer"},{"issue":"2","key":"pone.0344247.ref013","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting HER2-positive breast cancer: Advances and future directions","volume":"22","author":"SM Swain","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"pone.0344247.ref014","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: Future outlook","volume":"15","author":"O Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"pone.0344247.ref015","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.18632\/oncotarget.12284","article-title":"Triple-negative breast cancer: Is there a treatment on the horizon?","volume":"8","author":"H Yao","year":"2017","journal-title":"Oncotarget"},{"key":"pone.0344247.ref016","volume-title":"Cancer invasion and metastasis: molecular and cellular perspective","author":"TA Martin","year":"2013"},{"issue":"2","key":"pone.0344247.ref017","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10585-021-10144-5","article-title":"Current challenges in metastasis research and future innovation for clinical translation","volume":"39","author":"AL Parker","year":"2022","journal-title":"Clin Exp Metastasis"},{"key":"pone.0344247.ref018","first-page":"307","article-title":"Breast cancer brain metastases: New directions in systemic therapy","volume":"7","author":"NU Lin","year":"2013","journal-title":"Ecancermedicalscience"},{"issue":"5","key":"pone.0344247.ref019","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/annonc\/mdq429","article-title":"Treatment of metastatic breast cancer: Second line and beyond","volume":"22","author":"H Roch\u00e9","year":"2011","journal-title":"Ann Oncol"},{"issue":"8","key":"pone.0344247.ref020","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jamaoncol.2017.0001","article-title":"Brain metastases in newly diagnosed breast cancer: A population-based study","volume":"3","author":"AM Martin","year":"2017","journal-title":"JAMA Oncol"},{"key":"pone.0344247.ref021","doi-asserted-by":"crossref","first-page":"1431418","DOI":"10.3389\/fonc.2024.1431418","article-title":"Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer","volume":"14","author":"M Haque","year":"2024","journal-title":"Front Oncol"},{"key":"pone.0344247.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4020-5867-7_1","article-title":"Metastasis of breast cancer: An introduction","volume-title":"Metastasis of Breast Cancer","author":"RE Mansel","year":"2007"},{"issue":"8","key":"pone.0344247.ref023","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrc1670","article-title":"Breast cancer metastasis: Markers and models","volume":"5","author":"B Weigelt","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"pone.0344247.ref024","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.3390\/cancers16091632","article-title":"Evidence and future perspectives for neoadjuvant therapy for resectable and borderline resectable pancreatic cancer: A scoping review","volume":"16","author":"Y Endo","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"pone.0344247.ref025","first-page":"3","article-title":"Chances, risks and limitations of neoadjuvant therapy in surgical oncology","volume":"1","author":"F Lordick","year":"2016","journal-title":"Innov Surg Sci"},{"issue":"10","key":"pone.0344247.ref026","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1369\/0022155415595670","article-title":"The study of glioma by xenotransplantation in zebrafish early life stages","volume":"63","author":"M Vittori","year":"2015","journal-title":"J Histochem Cytochem"},{"key":"pone.0344247.ref027","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/BD-2010-0307","article-title":"Triple negative breast cancer cell lines: One tool in the search for better treatment of triple negative breast cancer","volume":"32","author":"KJ Chavez","year":"2010","journal-title":"Breast Dis"},{"issue":"1","key":"pone.0344247.ref028","doi-asserted-by":"crossref","first-page":"13856","DOI":"10.1038\/s41598-017-14364-2","article-title":"Unraveling the roles of CD44\/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis","volume":"7","author":"W Li","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0344247.ref029","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/bcr1673","article-title":"Human breast cancer stem cell markers CD44 and CD24: Enriching for cells with functional properties in mice or in man?","volume":"9","author":"C Fillmore","year":"2007","journal-title":"Breast Cancer Res"},{"key":"pone.0344247.ref030","doi-asserted-by":"crossref","first-page":"1540610","DOI":"10.3389\/fimmu.2025.1540610","article-title":"Zebrafish xenografts in breast cancer research","volume":"16","author":"X Rong","year":"2025","journal-title":"Front Immunol"},{"key":"pone.0344247.ref031","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.940550","article-title":"Advancements in zebrafish models for breast cancer research: Unveiling biomarkers, targeted therapies, and personalized medicine","volume":"29","author":"A Wawruszak","year":"2023","journal-title":"Med Sci Monit"},{"issue":"42","key":"pone.0344247.ref032","doi-asserted-by":"crossref","first-page":"68803","DOI":"10.18632\/oncotarget.11931","article-title":"A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo","volume":"7","author":"A Amaro","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"pone.0344247.ref033","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/cancers16040796","article-title":"Human breast cancer cell lines differentially modulate signaling from distant microenvironments, which reflects their metastatic potential","volume":"16","author":"R Ocadiz-Ruiz","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"pone.0344247.ref034","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s43556-022-00080-5","article-title":"Identifying drivers of breast cancer metastasis in progressively invasive subpopulations of zebrafish-xenografted MDA-MB-231","volume":"3","author":"J Xiao","year":"2022","journal-title":"Mol Biomed"},{"issue":"1","key":"pone.0344247.ref035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jtcme.2015.09.004","article-title":"Russian olive (Elaeagnus angustifolia L.): From a variety of traditional medicinal applications to its novel roles as active antioxidant, anti-inflammatory, anti-mutagenic and analgesic agent","volume":"7","author":"R Hamidpour","year":"2016","journal-title":"J Tradit Complement Med"},{"key":"pone.0344247.ref036","first-page":"1046","article-title":"Cancer chemoprevention by oleaster (Elaeagnus angustifoli L.) fruit extract in a model of hepatocellular carcinoma induced by diethylnitrosamine in rats","volume":"16","author":"Z Amereh","year":"2017","journal-title":"EXCLI J"},{"issue":"2","key":"pone.0344247.ref037","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/01635581.2018.1412472","article-title":"Elaeagnus angustifolia plant extract inhibits angiogenesis and downgrades cell invasion of human oral cancer cells via Erk1\/Erk2 inactivation","volume":"70","author":"AI Saleh","year":"2018","journal-title":"Nutr Cancer"},{"issue":"4","key":"pone.0344247.ref038","first-page":"231","article-title":"Phenolic and flavonoid content of Elaeagnus angustifolia L. (leaf and flower)","volume":"4","author":"F Saboonchian","year":"2014","journal-title":"Avicenna J Phytomed"},{"issue":"2","key":"pone.0344247.ref039","doi-asserted-by":"crossref","first-page":"163","DOI":"10.15171\/apb.2016.023","article-title":"Essential Oil from Flowers and Leaves of Elaeagnus Angustifolia (Elaeagnaceae): Composition, Radical Scavenging and General Toxicity Activities","volume":"6","author":"M Torbati","year":"2016","journal-title":"Adv Pharm Bull"},{"issue":"5","key":"pone.0344247.ref040","doi-asserted-by":"crossref","first-page":"707","DOI":"10.19026\/ajfst.6.98","article-title":"Antioxidant and Antitumor Effect of Different Fractions of Ethyl Acetate Part from Elaeagnus angustifolia L","volume":"6","author":"W Ya","year":"2014","journal-title":"AJFST"},{"issue":"3","key":"pone.0344247.ref041","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/10256010903084126","article-title":"Natural abundances of 15N and 13C in leaves of some N2-fixing and non-N2-fixing trees and shrubs in Syria","volume":"45","author":"F Kurdali","year":"2009","journal-title":"Isotopes Environ Health Stud"},{"key":"pone.0344247.ref042","doi-asserted-by":"crossref","first-page":"871667","DOI":"10.3389\/fnut.2022.871667","article-title":"Elaeagnus angustifolia Plant Extract Induces Apoptosis via P53 and Signal Transducer and Activator of Transcription 3 Signaling Pathways in Triple-Negative Breast Cancer Cells","volume":"9","author":"A Fouzat","year":"2022","journal-title":"Front Nutr"},{"issue":"18","key":"pone.0344247.ref043","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.3390\/molecules25184240","article-title":"Elaeagnus angustifolia Plant Extract Inhibits Epithelial-Mesenchymal Transition and Induces Apoptosis via HER2 Inactivation and JNK Pathway in HER2-Positive Breast Cancer Cells","volume":"25","author":"A Jabeen","year":"2020","journal-title":"Molecules"},{"issue":"31","key":"pone.0344247.ref044","first-page":"4633","article-title":"In vitro anti-angiogenic activity fractions from hydroalcoholic extract of Elaeagnus angustifolia L. flower and Nepeta crispa L. arial part","volume":"6","author":"A Badrhadad","year":"2012","journal-title":"J Med Plants Res"},{"key":"pone.0344247.ref045","unstructured":"Reed B, Jennings M. Guidance on the housing and care of zebrafish Danio rerio. 2011."},{"issue":"2","key":"pone.0344247.ref046","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ilar.53.2.192","article-title":"Anesthesia and euthanasia in zebrafish","volume":"53","author":"M Matthews","year":"2012","journal-title":"ILAR J"},{"issue":"2","key":"pone.0344247.ref047","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jat.4380","article-title":"Evaluation of the effect of green tea and its constituents on embryo development in a zebrafish model","volume":"43","author":"Q Zhang","year":"2023","journal-title":"J Appl Toxicol"},{"issue":"3","key":"pone.0344247.ref048","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10565-018-09453-5","article-title":"The effects of five types of tea solutions on epiboly process, neural and cardiovascular development, and locomotor capacity of zebrafish","volume":"35","author":"X Li","year":"2019","journal-title":"Cell Biol Toxicol"},{"key":"pone.0344247.ref049","volume-title":"The zebrafish book: a guide for the laboratory use of zebrafish","author":"M Westerfield","year":"2000"},{"issue":"3","key":"pone.0344247.ref050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.aquatox.2008.11.009","article-title":"Benefits of the maximum tolerated dose (MTD) and maximum tolerated concentration (MTC) concept in aquatic toxicology","volume":"91","author":"TH Hutchinson","year":"2009","journal-title":"Aquat Toxicol"},{"key":"pone.0344247.ref051","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/bs.ctdb.2016.10.007","article-title":"Zebrafish in toxicology and environmental health","volume":"124","author":"K Bambino","year":"2017","journal-title":"Curr Top Dev Biol"},{"issue":"3","key":"pone.0344247.ref052","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.yrtph.2005.05.004","article-title":"The no-observed-adverse-effect-level in drug safety evaluations: Use, issues, and definition(s)","volume":"42","author":"MA Dorato","year":"2005","journal-title":"Regul Toxicol Pharmacol"},{"issue":"10","key":"pone.0344247.ref053","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/bcp.14032","article-title":"Why maximum tolerated dose?","volume":"85","author":"HG Stampfer","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"pone.0344247.ref054","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/01926230252824725","article-title":"Recognition of adverse and nonadverse effects in toxicity studies","volume":"30","author":"RW Lewis","year":"2002","journal-title":"Toxicol Pathol"},{"key":"pone.0344247.ref055","doi-asserted-by":"crossref","DOI":"10.5339\/qfarc.2018.HBPD769","article-title":"Generating an imagingbased approach for enhanced structural and functional analysis of zebrafish cardiovascular systems","author":"H Yalcin","year":"2018","journal-title":"Qatar Foundation Annual Research Conference Proceedings"},{"issue":"11","key":"pone.0344247.ref056","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/dvdy.24497","article-title":"Heart function and hemodynamic analysis for zebrafish embryos","volume":"246","author":"HC Yalcin","year":"2017","journal-title":"Dev Dyn"},{"key":"pone.0344247.ref057","doi-asserted-by":"crossref","first-page":"104812","DOI":"10.1016\/j.dib.2019.104812","article-title":"Zebrafish (Danio rerio) embryo-larvae locomotor activity data analysis: Evaluating anxiolytic effects of the antidepressant compound citalopram","volume":"27","author":"J Pohl","year":"2019","journal-title":"Data Brief"},{"issue":"4","key":"pone.0344247.ref058","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/ijms18040864","article-title":"ZeGlobalTox: An Innovative Approach to Address Organ Drug Toxicity Using Zebrafish","volume":"18","author":"C Cornet","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pone.0344247.ref059","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/zeb.2015.1170","article-title":"Developing a novel embryo-larval zebrafish xenograft assay to prioritize human glioblastoma therapeutics","volume":"13","author":"LC Wehmas","year":"2016","journal-title":"Zebrafish"},{"issue":"3","key":"pone.0344247.ref060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10456-006-9040-2","article-title":"Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish","volume":"9","author":"M Haldi","year":"2006","journal-title":"Angiogenesis"},{"issue":"10","key":"pone.0344247.ref061","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3390\/nu15102369","article-title":"Testing the anticancer effect of matcha using zebrafish as an animal model","volume":"15","author":"S Sokary","year":"2023","journal-title":"Nutrients"},{"key":"pone.0344247.ref062","unstructured":"El-Sharkawey A. Calculate the Corrected Total Cell Fluorescence (CTCF). 2016."},{"key":"pone.0344247.ref063","doi-asserted-by":"crossref","first-page":"1405491","DOI":"10.3389\/fonc.2024.1405491","article-title":"Advancements and challenges in triple-negative breast cancer: A comprehensive review of therapeutic and diagnostic strategies","volume":"14","author":"N Xiong","year":"2024","journal-title":"Front Oncol"},{"key":"pone.0344247.ref064","doi-asserted-by":"crossref","unstructured":"Mohamed I, et al. Elaeagnus angustifolia: A promising medicinal plant for cancer therapy. 2020.","DOI":"10.29117\/quarfe.2020.0124"},{"issue":"11","key":"pone.0344247.ref065","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/genes10110935","article-title":"Zebrafish models of cancer-new insights on modeling human cancer in a non-mammalian vertebrate","volume":"10","author":"M Hason","year":"2019","journal-title":"Genes (Basel)"},{"key":"pone.0344247.ref066","doi-asserted-by":"crossref","unstructured":"Zakaria ZZ. Using zebrafish for investigating the molecular mechanisms of drug-induced cardiotoxicity. 2018.","DOI":"10.1155\/2018\/1642684"},{"issue":"8","key":"pone.0344247.ref067","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037077","article-title":"Zebrafish in vivo models of cancer and metastasis","volume":"10","author":"KR Astell","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"pone.0344247.ref068","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1023366117157","article-title":"PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro","volume":"79","author":"H Liu","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"pone.0344247.ref069","article-title":"Zebrafish xenografts to isolate unique human breast cancer metastatic cell populations","author":"J Xiao","year":"2021","journal-title":"bioRxiv"},{"issue":"1","key":"pone.0344247.ref070","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s13046-021-02173-5","article-title":"Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis","volume":"40","author":"R-Y Fan","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"pone.0344247.ref071","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1002\/cam4.2894","article-title":"Fangjihuangqi Decoction inhibits MDA-MB-231 cell invasion in vitro and decreases tumor growth and metastasis in triple-negative breast cancer xenografts tumor zebrafish model","volume":"9","author":"Y Guo","year":"2020","journal-title":"Cancer Med"},{"issue":"117","key":"pone.0344247.ref072","doi-asserted-by":"crossref","DOI":"10.3791\/55007","article-title":"Testing the vascular invasive ability of cancer cells in zebrafish (Danio rerio)","author":"EB Berens","year":"2016","journal-title":"J Vis Exp"},{"issue":"2","key":"pone.0344247.ref073","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ecoenv.2004.10.015","article-title":"Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals","volume":"63","author":"B Fraysse","year":"2006","journal-title":"Ecotoxicol Environ Saf"},{"issue":"4","key":"pone.0344247.ref074","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/107602960100700404","article-title":"Endothelial dysfunction in the pathogenesis of atherosclerosis","volume":"7","author":"P Poredos","year":"2001","journal-title":"Clin Appl Thromb Hemost"},{"issue":"11","key":"pone.0344247.ref075","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1096\/fba.2021-00081","article-title":"In vivo imaging of EVs in zebrafish: New perspectives from \u201cthe waterside\u201d","volume":"3","author":"V Verdi","year":"2021","journal-title":"FASEB Bioadv"},{"issue":"1","key":"pone.0344247.ref076","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines7010023","article-title":"Zebrafish larvae as a behavioral model in neuropharmacology","volume":"7","author":"RM Basnet","year":"2019","journal-title":"Biomedicines"},{"issue":"3","key":"pone.0344247.ref077","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bbadis.2010.10.011","article-title":"Behavioural assessments of neurotoxic effects and neurodegeneration in zebrafish","volume":"1812","author":"KB Tierney","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"pone.0344247.ref078","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/toxics12030178","article-title":"Behavioral studies of zebrafish reveal a new perspective on the reproductive toxicity of micro- and nanoplastics","volume":"12","author":"B Wu","year":"2024","journal-title":"Toxics"},{"key":"pone.0344247.ref079","doi-asserted-by":"crossref","first-page":"107081","DOI":"10.1016\/j.envint.2022.107081","article-title":"Induction of lipid metabolism dysfunction, oxidative stress and inflammation response by tris(1-chloro-2-propyl)phosphate in larval\/adult zebrafish","volume":"160","author":"J Yan","year":"2022","journal-title":"Environ Int"},{"issue":"2","key":"pone.0344247.ref080","doi-asserted-by":"crossref","DOI":"10.1007\/s10989-022-10376-3","article-title":"Lipid-Lowering and Antioxidant Activity of RF13 Peptide From Vacuolar Protein Sorting-Associated Protein 26B (VPS26B) by Modulating Lipid Metabolism and Oxidative Stress in HFD Induced Obesity in Zebrafish Larvae","volume":"28","author":"A Guru","year":"2022","journal-title":"Int J Pept Res Ther"},{"issue":"6","key":"pone.0344247.ref081","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1053\/j.gastro.2015.08.034","article-title":"Zebrafish: An important tool for liver disease research","volume":"149","author":"W Goessling","year":"2015","journal-title":"Gastroenterology"},{"issue":"7","key":"pone.0344247.ref082","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/fishes8070342","article-title":"Morphological and Functional Alterations in Zebrafish (Danio rerio) Liver after Exposure to Two Ecologically Relevant Concentrations of Lead","volume":"8","author":"R Macirella","year":"2023","journal-title":"Fishes"},{"issue":"1","key":"pone.0344247.ref083","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12935-023-02960-4","article-title":"Flavonoids target different molecules of autophagic and metastatic pathways in cancer cells","volume":"23","author":"A Hosseinzadeh","year":"2023","journal-title":"Cancer Cell Int"},{"issue":"9","key":"pone.0344247.ref084","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3390\/ph16091229","article-title":"Anticancer potential of flavonoids: An overview with an emphasis on tangeretin","volume":"16","author":"FCF de Luna","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"pone.0344247.ref085","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.3390\/ijms26062678","article-title":"Prunin: An emerging anticancer flavonoid","volume":"26","author":"JN Rana","year":"2025","journal-title":"Int J Mol Sci"},{"key":"pone.0344247.ref086","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.sajb.2023.05.025","article-title":"Flavonoids as omnipotent candidates for cancer management","volume":"158","author":"P Chand","year":"2023","journal-title":"South African Journal of Botany"},{"key":"pone.0344247.ref087","doi-asserted-by":"crossref","first-page":"112442","DOI":"10.1016\/j.biopha.2021.112442","article-title":"Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms","volume":"146","author":"H Slika","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"pone.0344247.ref088","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10555-023-10134-x","article-title":"Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling","volume":"43","author":"P Kubatka","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"pone.0344247.ref089","doi-asserted-by":"crossref","unstructured":"Imraish A, et al. Anti\u2010Inflammatory and Antioxidant Potential of Green Synthesized Iron Zinc Oxide (Fe0. 25\u2010ZnO) Nanoparticles of the Elaeagnus angustifolia. Chemistry & Biodiversity, 2024: e202401060.","DOI":"10.1002\/cbdv.202401060"},{"issue":"11","key":"pone.0344247.ref090","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1096\/fj.10-161018","article-title":"Live imaging of apoptotic cells in zebrafish","volume":"24","author":"TJ van Ham","year":"2010","journal-title":"FASEB J"},{"issue":"1","key":"pone.0344247.ref091","doi-asserted-by":"crossref","first-page":"13254","DOI":"10.1038\/s41598-020-69956-2","article-title":"Long-term in vivo imaging reveals tumor-specific dissemination and captures host tumor interaction in zebrafish xenografts","volume":"10","author":"N Asokan","year":"2020","journal-title":"Sci Rep"},{"issue":"15","key":"pone.0344247.ref092","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1055\/a-0633-9492","article-title":"A pharmacological update of ellagic acid","volume":"84","author":"JL R\u00edos","year":"2018","journal-title":"Planta Med"},{"issue":"7","key":"pone.0344247.ref093","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/jpm15070304","article-title":"Zebrafish as a model for translational immuno-oncology","volume":"15","author":"GR Barbosa","year":"2025","journal-title":"J Pers Med"},{"issue":"1","key":"pone.0344247.ref094","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41523-022-00411-3","article-title":"PARP inhibition in breast cancer: Progress made and future hopes","volume":"8","author":"N Tung","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"pone.0344247.ref095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer","volume":"387","author":"J Cortes","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0344247.ref096","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41523-023-00508-3","article-title":"Immunotherapy in breast cancer: An overview of current strategies and perspectives","volume":"9","author":"V Debien","year":"2023","journal-title":"NPJ Breast Cancer"},{"issue":"16","key":"pone.0344247.ref097","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab govitecan in metastatic triple-negative breast cancer","volume":"384","author":"A Bardia","year":"2021","journal-title":"New England Journal of Medicine"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:40:59Z","timestamp":1772822459000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344247"}},"subtitle":[],"editor":[{"given":"Hamida Hamdi Mohammed","family":"Ismail","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":97,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0344247","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]}}}